Trademark owner · USPTO register · rebuilt nightly

Immunitybio, Inc.

105 live US trademarks, filing since 2009. 6 new applications filed this year.

Live marks
105
registered + pending
Registered
15
on the Principal Register
Pending
90
1 open to opposition
Filed in 2026
6
2 intent to use
Classes used
9
of 45 Nice classes
First filing
2009
17 years on the register
At a glanceplain-language reads of the register
Mostly pharmaceuticals: 89 of 105 live marks are in Class 5. Science & technology (SaaS) (Class 42) is next with 27.
New products ahead: 2 of the 6 filings this year are intent-to-use applications, meaning the goods are not yet on sale.
Entering Class 35 (advertising & business) and Class 40 (materials treatment): first filings this year in a class with no earlier Immunitybio, Inc. marks.
One mark is open to opposition now; the window closes Oct 29.
3 registrations have a maintenance filing due in the next 12 months, 1 already in the grace period.
Filing activityapplications per year, by filing date
0 72 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 6 so far

Marks held on the register, by filing date. 2026 is year to date.

Portfolio by classlive marks · rank among filers in that class

A multi-class mark counts once per class. Rank shown where the owner is in the class's top 50.

Latest activity

What Immunitybio, Inc. filed most recently.

MarkClassFiledBasisStatusSerial
CONTINUUM 35, 42 Jun 5, 2026 intent to use pending 99868089
MYIB 9, 42 Jun 4, 2026 intent to use published · closes Dec 10 99864459
TVRIX 5 Apr 10, 2026 — published 99755808
NKVAX 5 Apr 10, 2026 — published 99755824
TRI-OFFENSE 5, 9, 16, 42, 44 Mar 5, 2026 — published 99685145
WORLD BANK OF NK 40, 44 Feb 13, 2026 — pending 99651257
HLASCORE 16, 44 Dec 15, 2025 — pending 99548361
MHCSCORE 16, 44 Dec 3, 2025 — published 99527229
ANKTIVA THE NK CELL GROWTH FACTOR 5 Dec 3, 2025 — published 99527269
RBCG 5 Dec 2, 2025 — pending 99524808
Open to opposition now30-day windows from publication
ESSENTAVAX · Cl. 5 · published Sep 29
closes Oct 29

Anyone who believes they would be harmed by registration can oppose during this window.

Maintenance windows aheadnext 12 months · from registration dates
NATURE'S FIRST RESPONDER · Reg. 6,059,246 · registered May 2020
Section 8 declaration (years 5–6) · in grace period until Nov 19, 2026
May 19, 2025 → May 19, 2026
INFACELL · Reg. 5,075,245 · registered Nov 2016
Section 8 & 9 renewal (year 10)
Nov 1, 2025 → Nov 1, 2026
HANK · Reg. 5,078,785 · registered Nov 2016
Section 8 & 9 renewal (year 10)
Nov 8, 2025 → Nov 8, 2026

A filing missed by the due date enters a six-month grace period, then the registration cancels.

Other large filers in Class 5Full ranking →
Common questions

About Immunitybio, Inc. trademarks.

How many trademarks does Immunitybio, Inc. have?

105 live US trademarks as of October 23, 2026: 15 registered and 90 pending applications. 6 were filed in 2026 so far.

What does Immunitybio, Inc. sell, according to its trademarks?

Mostly pharmaceuticals (Class 5, 89 live marks). Also science & technology (saas) (Class 42) and medical & beauty services (Class 44).

Who owns the CONKWEST trademark?

CONKWEST is owned by Immunitybio, Inc.. It was registered on February 15, 2011 (Reg. No. 3920852) and is live. The same owner holds 104 other live US marks.

When did Immunitybio, Inc. first file a trademark?

Its oldest live US filing dates from 2009: CONKWEST, filed November 5, 2009.

Know the morning after Immunitybio, Inc. files.

Watch this company in Thorgate and get an alert for every new application, registration, publication and lapse, with the opposition deadline already worked out. Or monitor your own marks for conflicts with theirs.

Data: USPTO trademark bulk files, processed nightly by Thorgate. Last rebuilt October 23, 2026. Counts cover the US federal register only, not state or foreign marks. Owner names are shown as recorded by the USPTO. This page reports public-record facts and dates and is not legal advice. For the official record of any mark, follow its serial number to USPTO TSDR.